GE HealthCare Updates Intelligent Radiation Therapy Software to Shorten Workflow

GE HealthCare Technologies Inc. (NASDAQ:GEHC) is one of the most promising stocks under $100. On September 25, GE HealthCare announced updates to its Intelligent Radiation Therapy/iRT software solution. The AI-supported solution improves and shortens the radiation therapy workflow, which is a treatment that ~60% of cancer patients receive, but which can take up to 30 days even just to begin.

Early adopters have shown a reduction in the time from simulation to treatment planning, from 7 days to 7 minutes, through integration with RayStation by RaySearch Laboratories. The new version of iRT enhances connectivity and uses insights to improve departmental efficiency. This addresses the challenge of complex radiation oncology workflows where manual data re-entry across disconnected systems can waste time and increase error risk.

The solution is vendor-neutral, managing data between various systems. GE HealthCare also showed a new capability for theranostics within iRT. Theranostics is a part of nuclear medicine that uses molecular imaging and targeted radionuclide therapies for the same biological target.

GE HealthCare Technologies Inc. (NASDAQ:GEHC) develops, manufactures, and markets products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the US, Canada, and internationally.

While we acknowledge the potential of GEHC as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.